Simulations Plus, Inc. is a provider in the biopharma sector, offering advanced software and consulting services that enhance drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. It operates through two segments: software and services. The Companyโs business units include cheminformatics, physiologically based pharmacokinetics, clinical pharmacology and pharmacometrics, quantitative systems pharmacology, adaptive learning & insights and medical communications. The Company operates in biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry. It delivers simulation-enabled performance and intelligence solutions alongside medical communications support for clinical and commercial drug development. Its cutting-edge technology is licensed and utilized by pharmaceutical, biotechnology, and regulatory agencies worldwide.
๋์ ์ฑ์ฅ
ํ์ฌ์ ๋งค์ถ์ ์ง๋ 3๋
๊ฐ ๊พธ์คํ ์ฑ์ฅํด์์ผ๋ฉฐ, ์ฐํ๊ท 32.90%์ ์ฆ๊ฐ์จ์ ๊ธฐ๋กํ์ต๋๋ค.
์ฑ์ฅ ์ค
ํ์ฌ๋ ์ฑ์ฅ ๋จ๊ณ์ ์์ผ๋ฉฐ, ์ต์ ์ฐ๊ฐ ์์ต์ ๋ฏธํ 79.18M์ ๋ฌํฉ๋๋ค.
์์ค ์ ํ
ํ์ฌ์ ์ค์ ์ด ์ ์๋ก ์ ํ๋์ด, ์ต๊ทผ ์ฐ๊ฐ ์์ค์ ๋ฏธํ ๋ฌ๋ฌ์ ๋ฌํฉ๋๋ค
๊ณผ์ ํ๊ฐ๋
ํ์ฌ์ ์ต์ PE์ -5.83๋ก, ์ต๊ทผ 3๋
๊ธฐ์ค ๋ฎ์ ๋ฐฑ๋ถ์ ๋ฒ์์ ์ํฉ๋๋ค.
๊ธฐ๊ด ๋งค๋
์ต์ ๊ธฐ๊ด ๋ณด์ ์ฃผ์ ์๋ 17.68M์ฃผ์ด๋ฉฐ, ์ ๋ถ๊ธฐ ๋๋น 20.75% ๊ฐ์ํ์ต๋๋ค.
์ฒ ๋ก์ด์ค๊ฐ ๋ณด์
์คํ ํฌ์์ ์ฒ ๋ก์ด์ค์ด(๊ฐ) ์ด ์ฃผ์ 324.76K์ฃผ๋ฅผ ๋ณด์ ํ๊ณ ์์ต๋๋ค.